<DOC>
	<DOCNO>NCT00911794</DOCNO>
	<brief_summary>The purpose study determine whether Written Disclosure Therapy ( WDT ) benefit patient chronic lung disease participate pulmonary rehabilitation .</brief_summary>
	<brief_title>Written Disclosure Therapy Anxiety Stress Patients With Chronic Lung Disease</brief_title>
	<detailed_description>Chronic lung diseases typically associate impaired quality life , stress , anxiety . Written disclosure therapy ( WDT ) reduce stress patient variety chronic illness . We seek determine write disclosure therapy benefit patient chronic lung diseases added component pulmonary rehabilitation program .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<criteria>Diagnosis COPD Pulmonary Fibrosis First time participant Pulmonary Rehabilitation program Dementia Prior significant psychiatric illness Inability complete questionnaire Inability cooperate spirometry Inability participate outpatient followup sixmonth</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Dyspnea</keyword>
	<keyword>Written Disclosure Therapy</keyword>
	<keyword>COPD</keyword>
	<keyword>Pulmonary Fibrosis</keyword>
	<keyword>Chronic Lung Diseases</keyword>
	<keyword>Pulmonary Rehabilitation</keyword>
</DOC>